Summary
71 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 42% a year over the last 3 years.
- Out of every 100 USD of revenue, 15 USD is left as net profit.
- It has no debt and holds $2.24M in cash.
- The share price is below the Bulios Fair Price.
What to watch
- It earns only 5.0 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 2.1% a year over 5 years. Over the last 3 years it grew by 5.3% a year. Earnings per share grew by 42% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 54 USD
- Sales and administration 32 USD
- Taxes and other -0.8 USD
- Net profit 15 USD
Net profit, industry median (Medical - Healthcare Plans) 2.3 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- HCOMember 65%
- MPNMember 35%
By region
The company reports no revenue by region.
HCOMember brings in 65% of revenue. MPNMember grew fastest, by 5.7% a year.
Segments in detail